<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34080713</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1531-8257</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>36</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Movement disorders : official journal of the Movement Disorder Society</Title>
          <ISOAbbreviation>Mov Disord</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Availability of Therapies and Services for Parkinson's Disease in Africa: A Continent-Wide Survey.</ArticleTitle>
        <Pagination>
          <StartPage>2393</StartPage>
          <EndPage>2407</EndPage>
          <MedlinePgn>2393-2407</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.28669</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The growing burden of Parkinson's disease (PD) in Africa necessitates the identification of available therapies and services to improve patient care.</AbstractText>
          <AbstractText Label="OBJECTIVE">To investigate the availability, affordability, frequency of usage, and insurance coverage of PD therapies (pharmacological, surgical, physical, and speech therapies) and services including specialized clinics, specialists, and nurses across Africa.</AbstractText>
          <AbstractText Label="METHODS">A comprehensive web-based survey was constructed and distributed to neurologists/physicians with a special interest in PD across Africa. The survey instrument includes components that address availability, affordability, frequency of use, and insurance coverage of different therapies and services.</AbstractText>
          <AbstractText Label="RESULTS">Responses were received from 28 (of 43 contacted) countries. Levodopa-based oral preparations were always available in 13 countries (46.4%) with variable affordability and "partial or no" insurance coverage in 60% of countries. Bromocriptine was the most available (50%) and affordable ergot dopamine agonists (DA), whereas non-ergot DA was always available in only six countries (21.4%). Trihexyphenidyl was the most available and affordable anticholinergic drug (46.4%). Tricyclic antidepressants and selective serotonin reuptake inhibitors were available in most countries (89.3% and 85.7% respectively), with variable affordability. Quetiapine and clozapine were less available. Specialized clinics and nurses were available in 25% and 7.1% of countries surveyed, respectively. Other services were largely unavailable in the countries surveyed.</AbstractText>
          <AbstractText Label="CONCLUSION">PD-specific therapies and services are largely unavailable and unaffordable in most African countries. The data provide a platform for organizing strategies to initiate or scale up existing services and drive policies aimed at improving access to care and tailoring education programs in Africa. © 2021 International Parkinson and Movement Disorder Society.</AbstractText>
          <CopyrightInformation>© 2021 International Parkinson and Movement Disorder Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hamid</LastName>
            <ForeName>Eman</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ayele</LastName>
            <ForeName>Biniyam A</ForeName>
            <Initials>BA</Initials>
            <Identifier Source="ORCID">0000-0002-7955-6030</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Black Lion Specialized Hospital, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Massi</LastName>
            <ForeName>Daniel Gams</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>Douala General Hospital, Faculty of Health Sciences, University of Buea, Buea, Cameroon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ben Sassi</LastName>
            <ForeName>Samia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Mongi Ben Hamida National Institute of Neurology, Tunis, Tunisia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tibar</LastName>
            <ForeName>Houyam</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Regional Hospital of Guelmim, Guelmim, Morocco.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Djonga</LastName>
            <ForeName>Emmanuel Epenge</ForeName>
            <Initials>EE</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropsychopathologic Center, Kinshasa, Democratic Republic of The Congo.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Sadig</LastName>
            <ForeName>Sarah Misbah</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Soba University Hospital, Khartoum, Sudan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amer El Khedoud</LastName>
            <ForeName>Wahiba</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Algiers' Faculty of medicine; Ben Aknoun Hospital, Algiers, Algeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Razafimahefa</LastName>
            <ForeName>Julien</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Faculté Médecine Antananarivo, Hôpital Joseph Raseta Befelatanana, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kouame-Assouan</LastName>
            <ForeName>Ange Eric</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University and teaching hospital of Bouaké, Bouaké, Ivory Coast.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ben-Adji</LastName>
            <ForeName>Djibrilla</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Centre Hospitalier Régional de Maradi, Maradi, Niger.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lengané</LastName>
            <ForeName>Yilédoma Thierry Modeste</ForeName>
            <Initials>YTM</Initials>
            <AffiliationInfo>
              <Affiliation>Hôpital Saint Camille de Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Musubire</LastName>
            <ForeName>Abdu Kisekka</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Kiruddu National Referral Hospital, Kampala, Uganda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohamed</LastName>
            <ForeName>Muhyadin Hassan</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>East Africa University Hospital, Bossaso, Somalia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Phiri</LastName>
            <ForeName>Tiwonge Elisa</ForeName>
            <Initials>TE</Initials>
            <AffiliationInfo>
              <Affiliation>Queen Elizabeth Central Hospital, Blantyre, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nestor</LastName>
            <ForeName>Nsengiyumva</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Hope Africa University, Clinic Van Norman, Bujumbura, Burundi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alwahchi</LastName>
            <ForeName>Wael Abdulgader</ForeName>
            <Initials>WA</Initials>
            <AffiliationInfo>
              <Affiliation>Ali Omar Askar, Tripoli, Libya.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Neshuku</LastName>
            <ForeName>Saara Ndinelago</ForeName>
            <Initials>SN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal medicine, Division of Neurology, Intermediate Hospital Katutura, Windhoek, Namibia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ocampo</LastName>
            <ForeName>Cassandra</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>University of Botswana, Gaborone, Botswana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sakadi</LastName>
            <ForeName>Foksouna</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>University Hospital Center of National Reference, N'djamena, Chad.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maidal</LastName>
            <ForeName>Moulid Ali</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Specialized Care Center/ CNSS, Djibouti, Djibouti.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ngwende</LastName>
            <ForeName>Gift Wilson</ForeName>
            <Initials>GW</Initials>
            <AffiliationInfo>
              <Affiliation>University of Zimbabwe, Harare, Zimbabwe.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hooker</LastName>
            <ForeName>Juzor</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Aga Khan University Hospital, Nairobi, Kenya.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okeng'o</LastName>
            <ForeName>Kigocha</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Muhimbili National Hospital, Dar es Salaam, Tanzania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Charway-Felli</LastName>
            <ForeName>Augustina</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>37 Military Hospital, Accra, Ghana.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Atadzhanov</LastName>
            <ForeName>Masharip</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>University of Zambia, Lusaka, Zambia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carr</LastName>
            <ForeName>Jonathan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okubadejo</LastName>
            <ForeName>Njideka U</ForeName>
            <Initials>NU</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine, University of Lagos, Lagos State, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shalash</LastName>
            <ForeName>Ali</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-7012-5907</Identifier>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K43 TW010718</GrantID>
            <Acronym>TW</Acronym>
            <Agency>FIC NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Mov Disord</MedlineTA>
        <NlmUniqueID>8610688</NlmUniqueID>
        <ISSNLinking>0885-3185</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>46627O600J</RegistryNumber>
          <NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Africa</Keyword>
        <Keyword MajorTopicYN="Y">Parkinson's disease</Keyword>
        <Keyword MajorTopicYN="Y">affordability</Keyword>
        <Keyword MajorTopicYN="Y">availability</Keyword>
        <Keyword MajorTopicYN="Y">therapies</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>3</Day>
          <Hour>8</Hour>
          <Minute>50</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34080713</ArticleId>
        <ArticleId IdType="doi">10.1002/mds.28669</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Dorsey ER, Bloem BR. The Parkinson pandemic - a call to action. JAMA Neurol 2018;75(1):9-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Ray Dorsey E, Elbaz A, Nichols E, et al. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):939-953.</Citation>
        </Reference>
        <Reference>
          <Citation>Fahn S. The 200-year journey of Parkinson disease: reflecting on the past and looking towards the future. Parkinsonism Relat Disord 2018;46:S1-S5.</Citation>
        </Reference>
        <Reference>
          <Citation>Radder DLM, de Vries NM, Riksen NP, et al. Multidisciplinary care for people with Parkinson's disease: the new kids on the block! Expert Rev Neurother 2019;19(2):145-157.</Citation>
        </Reference>
        <Reference>
          <Citation>World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. 2015. https://www.un.org/en/development/desa/publications/world-population-prospects-2015-revision.html</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Atlas - Country resources for neurological disorders 2017. https://www.who.int/mental_health/neurology/atlas_second_edition/en/</Citation>
        </Reference>
        <Reference>
          <Citation>Okubadejo NU, Ojo OO, Wahab KW, et al. A nationwide survey of Parkinson's disease medicines availability and affordability in Nigeria. Mov Disord Clin Pract 2019;6(1):27-33.</Citation>
        </Reference>
        <Reference>
          <Citation>Mokaya J, Dotchin CL, Gray WK, Hooker J, Walker RW. The accessibility of Parkinson's disease medication in Kenya: results of a national survey. Mov Disorders Clin Pract 2016;3(4):376-381.</Citation>
        </Reference>
        <Reference>
          <Citation>Lim SY, Tan AH, Ahmad-Annuar A, et al. Parkinson's disease in the Western Pacific region. Lancet Neurol 2019;18(9):865-879.</Citation>
        </Reference>
        <Reference>
          <Citation>Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One 2017;12(2):1-13.</Citation>
        </Reference>
        <Reference>
          <Citation>El-Tallawy HNA, Farghaly WMA, Rageh TA, et al. Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt. Neuropsychiatric Disease and Treatment 2013;9:767-771.</Citation>
        </Reference>
        <Reference>
          <Citation>Khedr EM, Al Attar GS, Kandil MR, Kamel NF, Abo Elfetoh N, Ahmed MA. Epidemiological study and clinical profile of parkinson's disease in the assiut governorate, egypt: a community-based study. Neuroepidemiology 2012;38(3):154-163.</Citation>
        </Reference>
        <Reference>
          <Citation>Khedr EM, Fawi G, Abd Abbas MA, et al. Prevalence of Parkinsonism and Parkinson's disease in Qena governorate/Egypt: a cross-sectional community-based survey. Neurological Research 2015;37(7):607-618.</Citation>
        </Reference>
        <Reference>
          <Citation>El-Tallawy HN, Farghaly WM, Shehata GA, et al. Prevalence of Parkinson's disease and other types of Parkinsonism in Al Kharga district, Egypt. Neuropsychiatric Disease and Treatment 2013;9:1821-1826. http://dx.doi.org/10.2147/ndt.s48318.</Citation>
        </Reference>
        <Reference>
          <Citation>Tekle- Haimanot R, Abebe M, Gebre-Mariam A, et al. Community-based study of neurological disorders in rural central ethiopia. neuroepidemiology 1990;9(5):263-277.</Citation>
        </Reference>
        <Reference>
          <Citation>Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinson's disease in Benghazi, North-East Libya. Clinical Neurology and Neurosurgery 1986;88(2):109-113.</Citation>
        </Reference>
        <Reference>
          <Citation>Osuntokun BO, Adeuja AOG, Schoenberg BS, et al. Neurological disorders in Nigerian Africans: a community-based study. Acta Neurologica Scandinavica 1987;75(1):13-21.</Citation>
        </Reference>
        <Reference>
          <Citation>Schoenberg BS, Osuntokun BO, Adeuja AOG, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies. Neurology 1988;38(4):645.</Citation>
        </Reference>
        <Reference>
          <Citation>Dotchin C, Msuya O, Kissima J, et al. The prevalence of Parkinson's disease in rural Tanzania. Movement Disorders 2008;23(11):1567-1672.</Citation>
        </Reference>
        <Reference>
          <Citation>Attia Romdhane N, Ben Hamida M, Mrabet A, et al. Prevalence Study of Neurologic Disorders in Kelibia (Tunisia). Neuroepidemiology 1993;12(5):285-299.</Citation>
        </Reference>
        <Reference>
          <Citation>GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396(10258):1204-1222.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Atlas: country resources for neurological disorders 2004 : results of a collaborative study of the World Health Organization and the World Federation of Neurology. World Health Organization. https://apps.who.int/iris/handle/10665/43075.</Citation>
        </Reference>
        <Reference>
          <Citation>Fothergill-Misbah N, Maroo H, Cham M, Pezzoli G, Walker R, Cilia R. Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?. Parkinsonism &amp; Related Disorders 2020;73:3-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Cubo E, Doumbe J, Martinez-Martin P, et al. Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian Cohorts. Journal of the Neurological Sciences 2014;336(1-2):122-126.</Citation>
        </Reference>
        <Reference>
          <Citation>Cilia R, Akpalu A, Sarfo FS, et al. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa. Brain. 2014;137(10):2731-2742.</Citation>
        </Reference>
        <Reference>
          <Citation>Cubo E, Gabriel-Galan JM, Martinez JS, et al. Comparison of office-based versus home web-based clinical assessments for Parkinson's disease. Movement Disorders 2012;27(2):308-311.</Citation>
        </Reference>
        <Reference>
          <Citation>Hassan A, Mari Z, Gatto EM, et al. Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic. Movement Disorders 2020;35(10):1701-1711.</Citation>
        </Reference>
        <Reference>
          <Citation>Bloem BR, Henderson EJ, Dorsey ER, et al. Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care. The Lancet Neurology 2020;19(7):623-634.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
